David Carbone, MD, PhD, a survivor of lymphoma and director, James Thoracic Center, The Ohio State University Comprehensive Cancer - The James, discusses pain management in the context of being a patient and a physician.
David Carbone, MD, PhD, a survivor of lymphoma and director, James Thoracic Center, The Ohio State University Comprehensive Cancer — The James, discusses pain management in the context of being a patient and a physician.
Acalabrutinib Plus Chemoimmunotherapy Improves PFS in Mantle Cell Lymphoma
May 6th 2024Patients with untreated mantle cell lymphoma treated with acalabrutinib plus bendamustine and rituximab had significant improvements in progression-free survival compared with bendamustine and rituximab alone.